Tuong-An Wong
Family Medicine · Arlington, TXNPI 1396912853
Payments from drug & device makers
Across 331 payments — averaging $16.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Lilly USA, LLC$776
- Boehringer Ingelheim$545
- Astellas Pharma US Inc$455
- AstraZeneca$418
- Bayer$310
- plus $2K from 32 others
What the payments were for
- Food & beverage$5,20495%
- Education$2945%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 86 | $1,193 |
| Lilly USA, LLC | 46 | $776 |
| Boehringer Ingelheim | 40 | $545 |
| Astellas Pharma US Inc | 14 | $455 |
| AstraZeneca | 25 | $418 |
| Bayer | 17 | $310 |
| Novo Nordisk | 13 | $241 |
| Exact Sciences | 8 | $179 |
| Abbott | 7 | $160 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 8 | $129 |
| Johnson & Johnson | 9 | $116 |
| GSK | 6 | $110 |
| Otsuka America Pharmaceutical, Inc. | 4 | $92 |
| E.r. Squibb & Sons, L.L.C. | 5 | $79 |
| Kowa Pharmaceuticals America, Inc. | 5 | $76 |
| Pfizer | 4 | $65 |
| Idorsia Pharmaceuticals US Inc | 3 | $62 |
| Amgen | 3 | $58 |
| Supernus Pharmaceuticals, Inc. | 3 | $42 |
| Phathom Pharmaceuticals, Inc. | 2 | $40 |
| Novartis | 2 | $35 |
| Merck | 2 | $32 |
| Althera Pharmaceuticals LLC | 2 | $30 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $28 |
| Sanofi Pasteur Inc. | 2 | $27 |
| Tris Pharma Inc | 1 | $21 |
| Zyla Life Sciences, Inc. | 1 | $19 |
| Sanofi-aventis U.S. LLC | 1 | $19 |
| Medtronic | 1 | $17 |
| Dexcom, Inc. | 1 | $17 |
| Sunovion Pharmaceuticals Inc. | 1 | $16 |
| Sumitomo Pharma America, Inc. | 1 | $16 |
| Therapeuticsmd, Inc. | 1 | $13 |
| Amarin Pharma, Inc. | 1 | $13 |
| Shire North American Group Inc | 1 | $13 |
| Ironwood Pharmaceuticals, Inc | 1 | $13 |
| Genentech USA, Inc. | 1 | $12 |
| Teva Pharmaceuticals USA, Inc. | 1 | $12 |
How this compares
$5,498 in reported general payments places this provider in the 85th percentile of 8,760 family medicine providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 53 | $77,007 |
| OzempicSemaglutide | 46 | $66,428 |
| JardianceEmpagliflozin | 54 | $60,834 |
| TrulicityDulaglutide | 16 | $39,780 |
| JanuviaSitagliptin Phosphate | 26 | $39,439 |
| EliquisApixaban | 35 | $29,843 |
| LinzessLinaclotide | 30 | $27,424 |
| VraylarCariprazine Hcl | 16 | $25,322 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 35 | $22,625 |
| MyrbetriqMirabegron | 26 | $21,470 |
| XareltoRivaroxaban | 31 | $18,623 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 13 | $9,777 |
| SymbicortBudesonide/Formoterol Fumarate | 28 | $7,057 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 40 | $6,066 |
| Gabapentin | 310 | $5,868 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity | $776 | $116,78669 claims |
| Novo NordiskOzempic | $241 | $66,42846 claims |
| Boehringer IngelheimJardiance | $545 | $60,83454 claims |
| AbbVieLinzess, Vraylar | $1,193 | $52,74646 claims |
| MerckJanuvia | $32 | $39,43926 claims |
| PfizerEliquis | $65 | $29,84335 claims |
| GSKTrelegy Ellipta | $110 | $22,62535 claims |
| Astellas Pharma US IncMyrbetriq | $455 | $21,47026 claims |
| Johnson & JohnsonXarelto | $116 | $18,62331 claims |
| AstraZenecaBreztri Aerosphere, Symbicort | $418 | $16,83441 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 8,760 family medicine providers in Texas.
Other family medicine in Arlington
- Douglas DenhamSan Antonio$68.5M
- Vicki MillerPasadena$58.3M
- Hareshkumar BogharaDesoto$30.3M
- Earl MartinTomball$30.1M
- Lisa HollowayHouston$30.1M
- William SegerFort Worth$27.5M
- Veronica FragosoHouston$24.5M
- Joel SolisMcAllen$21.1M
- George AtieeSan Antonio$19.9M
- Bonnie ColvilleHouston$19.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.